Indication

Dyslipidemia, Hypertriglyceridaemin, Prophylaxis of myocardial infarction

Administration

Should be taken with food.

Adult Dose

Oral\r\nHypertriglyceridaemia\r\nAdult: 4 g once daily 2g twice daily.\r\n\r\nSecondary prophylaxis of myocardial infarction\r\nAdult: 1 g daily.

Child Dose

<18 years: Safety and efficacy not established\r\n\r\n

Contraindication

Patients with known hypersensitivity (e.g., anaphylactic reaction) to LOVAZA or any of its components.

Mode of Action

The omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid are long-chain n-3 polyunsaturated fatty acids, which compete with arachidonic acid for inclusion in cyclo-oxygenase and lipoxygenase pathways. Their actions include hypolipidaemic action (especially a reduction in plasma triglycerides) by reducing very-low-density lipoproteins; anti-inflammatory action, attributed to effects on leukotriene synthesis; and antiplatelet effect, attributed to effects on prostanoid synthesis, which promote vasodilatation, reduction in platelet aggregation, increased bleeding time and decreased platelet counts.

Precaution

Haemorrhagic disorders or those receiving anticoagulants or other drugs that have antithrombotic activity; asthmatic patients sensitive to aspirin. Monitor hepatic function in patients with hepatic impairment, especially if receiving high doses.\r\n\r\nLactation: Not known if excreted in breast milk; use caution

Side Effect

1-10%\r\nEructation (4.9%),Infection (4.4%),Flu-like syndrome (3.5%),Dyspepsia (3.1%),Taste perversion (2.7%),Back pain (2.2%),Pain (1.8%),Rash (1.8%),Angina pectoris (1.3%)